Nitric oxide released from activated platelets inhibits platelet recruitment

Journal of Clinical Investigation

Volumn 100, Issue 2, 1997, Pages 350-356

  Freedman, Jane E ^a   Loscalzo, Joseph ^a   Barnard, Marc R ^b   Alpert, Caroline ^a   Keaney Jr , John F ^a   Michelson, Alan D ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Blood platelet; Nitric oxide; Nitric oxide synthase; P selection; Thrombosis

Indexed keywords

BIOTIN; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PADGEM PROTEIN;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROELECTRODE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0030853312     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119540     Document Type: Article

References (34)

1. DeWood, M.A., J. Spores, R. Notske, L.T. Mouser, R. Burroughs, M.S. Golden, and H.T. Lang. 1980. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N. Engl. J. Med. 303:897-902.
2. Falk, E. 1985. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden dealth. Circulation. 71:699-708.
3. Fitzgerald, D.J., L. Roy, F. Catella, and G.A. Fitzgerald. 1986. Platelet activation in unstable coronary disease. N. Engl. J. Med. 315:983-989.
4. Little, W.C., M. Constantinescu, R.J. Applegate, M.A. Kutcher, M.T. Burrows, F.R. Kahl, and W.P. Santamore. 1988. Can coronary angiography predict the site of a subsequent myocardial infaction in patients with mild-to-moderate coronary artery disease? Circulation. 78:1157-1166.
5. Falk, E. 1983. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Br. Hrt. J. 127-134.
6. Davies, M.J., and A.C. Thomas. 1984. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310:1137-1140.
7. Santos, M.T., J. Valles, A.J. Marcus, L.B. Safier, J. Broekman, N. Islam, H.L. Ullman, A.M. Eiroa, and J. Aznar. 1991. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J. Clin. Invest. 87:571-580.
8. de Graaf, J.C., J.D. Banga, S. Moncada, R.M.J. Palmer, P.G. de Groot, and J.J. Sixma. 1992. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 85:2284-2290.
9. Broekman, M.J., A.M. Eiroa, and A.J. Marcus. 1991. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood. 78:1033-1040.
10. Stamler, J., M.E. Mendelsohn, P. Amarante, D. Smick, N. Andon, P.F. Davies, J.P. Cooke, and J. Loscalzo. 1989. N-Acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res. 65:789-795.
11. Cooke, J.P., J. Stamler, N. Andon, P.F. Davies, G. McKinley, and J. Loscalzo. 1990. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol.Am. J. Physiol. 259:H804-H812.
12. Shultz, P.J., and L. Raij. 1992. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 90:1718-1725.
13. Michelson, A.D., S.E. Benoit, M.I. Furman, W.L. Breckwoldt, M.J. Rohrer, M.R. Barnard, and J. Loscalzo. 1996. Effects of endothelium-derived relaxing factor/nitric oxide on platelet surface glycoproteins. Am. J. Physiol. 270:H1640-H1648.
14. Sase, K., and T. Michel. 1995. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 57:2049-2055.
15. Chen, L.Y., and J.L. Mehta. 1996. Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J. Pharm. Exp. Ther. 276:253-257.
16. Zhou, Q., G.R. Hellermann, and L.P. Solomonson. 1995. Nitric oxide release from resting human platelets. Thromb. Res. 77:87-96.
17. Simon, D.I., J.S. Stamler, E. Loh, J. Loscalzo, S.A. Frances, and M.A. Creager. 1995. Effect of nitric oxide synthase inhibition on bleeding time in humans. J. Cardiovasc. Pharmacol. 26:339-342.
18. Bodzenta-Lukaszyke, A., A. Gabryelewicz, A. Lukaszyk, M. Bielawiec, J.W. Konturek, and W. Domschke. 1994. Nitric oxide synthase inhibition and platelet function. Thromb. Res. 75:667-672.
19. Winn, R.K., D. Liggitt, N.B. Vedder, J.C. Paulson, and J.M. Harlan. 1993. Anti - P selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J. Clin. Invest. 92:2042-2047.
20. Kestin, A.S., CR. Valeri, S.F. Khuri, J. Loscalzo, P.A. Ellis, H. MacGregor, V. Birjiniuk, H. Ouimet, B. Pasche, M.J. Nelson, et al. 1993. The platelet function defect of cardiopulmonary bypass. Blood. 82:107-117.
21. Hawiger, J., S. Parkinson, and S. Timmons. 1980. Prostacyclin inhibits mobilization of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature (Lond.). 283:195-198.
22. Born, G.V., and M.J. Cross. 1963. The aggregation of blood platelets. J. Physiol. (Lond.). 168:178-195.
23. Ichimori, K., H. Ishida, M. Fukahori, H. Nakazawa, and E. Murakami. 1994. Practical nitric oxide measurement employing a nitric oxide-selective electrode. Rev. Sci. Instrum. 65:1-5.
24. Holmsen, H., and C.A. Dangelmaier. 1989. Measurement of secretion of serotonin. Methods Enzyrnol. 169:205-210.
25. Mellion, T.B., L.J. Ignarro, E.H. Ohlstein, E.G. Pontecorvo, A.L. Hyman, and P.J. Kadowitz. 1981. Evidence for the inhibitory role of guanosine 3′', 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57:946-955.
26. Adams, M.R., C.J. Forsyth, W. Jessup, J. Robinson, and D.S. Celermajer. 1995. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J. Am. Coll. Cardiol. 26: 1054-1061.
27. Malinski, T., M.W. Radomski, Z. Taha, and S. Moncada. 1993. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem. Biophys. Res. Commun. 194:960-965.
28. Radomski, M.W., R.M.J. Palmer, and S. Moncada. 1990. An L-arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87:5193-5197.
29. Valles, J., M.T. Santos, A.J. Marcus, L.B. Safier, M.J. Broekman, N. Islam, H.L. Ullman, and J. Aznar. 1993. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J. Clin. Invest. 92:1357-1365.
30. Yao, S.K., J.C. Ober, A. Krishnaswami, J.J. Ferguson, H.V. Anderson, P. Golino, L.M. Buja, and J.T. Willerson. 1992. Endogenous nitric oxide protects against platelet aggregations and cyclic flow variations in stenosis and endothelium injured arteries. Circulation. 86:1302-1309.
31. Celi, A., G. Pellegrini, R. Lorenzet, A. De Blasi, N. Ready, B.C. Furie, and B. Furie. 1994. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. USA. 91:8767-8771.
32. Palabrica, T., R. Lobb, B.C. Furie, M. Aronovitz, C. Benjami, Y-M. Hsu, S.A. Sajer, and B. Furie. 1992. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature (Lond.). 359:848-850.
33. Vita, J.A., C.B. Treasure, E.G. Nabel, J.M. McLenachan, R.D. Fish, A.C. Yeung, V.I. Vekshtein, A.P. Selwyn, and P. Ganz. 1990. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:491-497.
34. Freedman, J.E., B. Hankin, C. Alpert, J. Loscalzo, J.F. Keaney, Jr., and J.A. Vita. 1996. Impaired platelet production of nitric oxide in patients with coronary artery disease. Circulation. 94:I-402a (Abstr.).